{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:24:38Z","timestamp":1780471478748,"version":"3.54.1"},"reference-count":14,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,8,8]]},"abstract":"<jats:p>Macrophage activation syndrome (MAS) is a rare disease characterised by aberrant immune hyperactivation of T lymphocytes and macrophages driven by cytokine dysfunction. The HLH-2004 protocol is commonly used for the treatment of MAS, but significant toxicities are associated. We describe a case of MAS secondary to systemic lupus erythematosus in a young female that responded well to rituximab in lieu of etoposide. She continues to be in remission 1\u2009year following the completion of rituximab infusion and is maintained on hydroxychloroquine. This case highlights the need for further research on the use of rituximab and other available biologics in the setting of MAS in order to help guide further alternative treatment decisions.<\/jats:p>","DOI":"10.1136\/bcr-2017-221347","type":"journal-article","created":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T09:02:15Z","timestamp":1503306135000},"page":"bcr-2017-221347","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus"],"prefix":"10.1136","volume":"2017","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3832-2852","authenticated-orcid":false,"given":"Zachary","family":"Junga","sequence":"first","affiliation":[{"name":"Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodger","family":"Stitt","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Tracy","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Keith","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,8,21]]},"reference":[{"key":"2025082623542120000_2017.aug20_1.bcr-2017-221347.1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.39332","article-title":"Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European league against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology international trials organisation collaborative initiative","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025082623542120000_2017.aug20_1.bcr-2017-221347.2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039"},{"key":"2025082623542120000_2017.aug20_1.bcr-2017-221347.3","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025082623542120000_2017.aug20_1.bcr-2017-221347.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.04.034"},{"key":"2025082623542120000_2017.aug20_1.bcr-2017-221347.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-356261"},{"key":"2025082623542120000_2017.aug20_1.bcr-2017-221347.6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken342"},{"key":"2025082623542120000_2017.aug20_1.bcr-2017-221347.7","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000093"},{"key":"2025082623542120000_2017.aug20_1.bcr-2017-221347.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2012.11.025"},{"key":"2025082623542120000_2017.aug20_1.bcr-2017-221347.9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq133"},{"key":"2025082623542120000_2017.aug20_1.bcr-2017-221347.10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-551622"},{"key":"2025082623542120000_2017.aug20_1.bcr-2017-221347.11","first-page":"347","article-title":"B-cell targeted therapy in systemic lupus erythematosus: potential of rituximab","volume":"6","author":"Wiesik-Szewczyk","year":"2012","journal-title":"Biologics"},{"key":"2025082623542120000_2017.aug20_1.bcr-2017-221347.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067900","article-title":"CD20 antibody primes B lymphocytes for type I interferon production","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"key":"2025082623542120000_2017.aug20_1.bcr-2017-221347.13","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.874740"},{"key":"2025082623542120000_2017.aug20_1.bcr-2017-221347.14","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313504634"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-221347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:54:27Z","timestamp":1756277667000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-221347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,21]]},"references-count":14,"alternative-id":["10.1136\/bcr-2017-221347"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-221347","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,21]]}}}